InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Discover the complete record of transactions filed by PYKOSZ MICHAEL T, President of Health Care Delivery. Officer active across 1 companies, notably Oak Street Health, Inc.. In total, 30 filings have been recorded. Total volume traded: €27.9m. The latest transaction was disclosed on 31 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations30 total
€10,372417 shares@ €24.87320.0% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-001769:0·
€10,372417 shares@ €24.87320.1% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-001769·
€88,6554,761 shares@ €18.62110.6% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-070947·
€88,6554,761 shares@ €18.62110.3% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-070947:0·
€2m43,259 shares@ €34.903510.8% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-065473·
€2m43,259 shares@ €34.90355.4% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-065473:0·
€926,87023,833 shares@ €38.89026.6% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-062782·
€926,87023,833 shares@ €38.89023.3% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-062782:0·
€2m46,238 shares@ €35.921711.8% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-061254·
€2m46,238 shares@ €35.92175.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-061254:0·
€1m38,794 shares@ €35.83629.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-059877·
€1m38,794 shares@ €35.83624.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-059877:0·
€2m41,950 shares@ €42.874112.8% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-057252·
€2m41,950 shares@ €42.87416.4% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-057252:0·
€269,4396,280 shares@ €42.90431.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-055218·
€269,4396,280 shares@ €42.90431.0% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-055218:0·
€754,70319,477 shares@ €38.74845.4% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-054310·
€754,70319,477 shares@ €38.74842.7% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-054310:0·
€1m35,021 shares@ €39.7499.9% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-052317·
€1m35,021 shares@ €39.7495.0% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-052317:0·
€589,39710,872 shares@ €54.21234.2% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-049731·
€589,39710,872 shares@ €54.21232.1% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-049731:0·
€3m50,256 shares@ €51.868318.6% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-048498·
€3m50,256 shares@ €51.86839.3% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-048498:0·
€180,0023,473 shares@ €51.82911.3% of flow
Common Stock, $0.001 par value
SEC:0001209191-21-048212·
25 of 30 declarations
About PYKOSZ MICHAEL T
Michael T. Pykosz is a U.S. healthcare executive best known as the co-founder of Oak Street Health, where he served as Chief Executive Officer, Chairman, and Director. His career has been closely tied to the evolution of value-based primary care in the United States, particularly for Medicare beneficiaries. Before co-founding Oak Street Health in 2012, he worked as a Principal at Boston Consulting Group, a background that likely helped shape his strategic lens, operating discipline, and systems-level view of healthcare delivery. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1564406/000119312521079611/d93602dpre14a.htm?utm_source=openai)) At Oak Street Health, Pykosz led the build-out of a primary care platform focused on older adults, preventive care, care coordination, and patient experience. The company’s model emphasized team-based care, bringing together physicians, social workers, mental health professionals, and other support staff to address patients’ needs more holistically. In public statements, he consistently highlighted the importance of partnerships with payors and the need to redesign care delivery around better alignment, access, and outcomes. Under his leadership, Oak Street Health became widely recognized as a major value-based care company in the U.S. market. ([oakstreethealth.com](https://www.oakstreethealth.com/news/humana-and-oak-street-health-expand-access-and-improve-seniors-overall-wellness-through-accountable-care?utm_source=openai)) Following CVS Health’s acquisition of Oak Street Health, Pykosz remained in a senior leadership role within the broader enterprise. In January 2024, CVS Health formally appointed him President of Health Care Delivery after he had been serving in an interim capacity. That move reflected his experience leading healthcare organizations built around clinical integration, access expansion, and value-based operating models. Overall, his profile combines entrepreneurship, healthcare strategy, operational execution, and leadership experience in one of the most closely watched segments of U.S. healthcare. ([cvshealth.com](https://www.cvshealth.com/news/company-news/cvs-health-announces-leadership-appointments.html?utm_source=openai))
